Administration time-dependent effects of raloxifen in postmenopausal women with osteoporosis
Phase 4
- Conditions
- postmenopausal osteoporosis
- Registration Number
- JPRN-UMIN000002322
- Lead Sponsor
- Division of Clinical Pharmacology, Department of Pharmacology, School of Medicine, Jichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 64
Inclusion Criteria
Not provided
Exclusion Criteria
Treatment with raloxifene or bisphosphonate in the preceding 12 months Anticoagulant therapy Inpatients Current or previous venous thromboembolism Bedridden subjects Antiphospholipid antibody syndrome Possibility of pregnancy Hypersensitivity to raloxifene Severe hepatic impairment Severe renal dysfunction Other unsuitableness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method